Interferon-gamma attenuates hemorrhage-induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis.
Although it is known that interferon-gamma synthesis and macrophage functions are depressed after hemorrhage, it remains to be determined whether systemic administration of interferon-gamma has any effect on hemorrhage-induced depression of macrophage and splenocyte functions. To study this, C3H/HEN mice were bled to a mean blood pressure of 35 mm Hg, maintained for 60 minutes, and followed by adequate fluid resuscitation. The mice then received either 1000 units interferon-gamma or saline solution (vehicle). Peritoneal (pM phi) and splenic (sM phi) macrophages and splenocytes were isolated 24 hours later. PM phi antigen presentation was measured by coculturing pM phi with the D10.G4.1 cell clone. Major histocompatibility complex class II (Ia) antigen expression was determined by direct immunofluorescence. Cytokine release by pM phi, sM phi, and splenocytes was assessed with specific bioassays. For survival studies, mice were subjected to sepsis 3 days after hemorrhage. Treatment with interferon-gamma restored (p less than or equal to 0.05) hemorrhage-induced suppression of pM phi antigen presentation capacity and Ia antigen expression and increased (p less than or equal to 0.05) interleukin-1 and tumor necrosis factor release by pM phi and sM phi, as well as splenocyte proliferation (p less than or equal to 0.05). Interferon-gamma also decreased (p less than or equal to 0.007) the susceptibility to sepsis after hemorrhage. Thus interferon-gamma represents a potent agent for treating hemorrhagic shock-induced immunosuppression and for increasing the ability of the host defense system to combat bacterial infections after hemorrhage.
Ertel
W
W
Department of Surgery, Michigan State University, East Lansing 48824-1315.
Morrison
M H
MH
Ayala
A
A
Dean
R E
RE
Chaudry
I H
IH
D000818:Animals; D000938:Antigen-Presenting Cells / Q000502:physiology; D002432:Cecum; D002455:Cell Division; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000378:metabolism; D004198:Disease Susceptibility; D006470:Hemorrhage / Q000473:pathology / Q000503:physiopathology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D007239:Infections / Q000209:etiology*; D007371:Interferon-gamma / Q000494:pharmacology*; D008026:Ligation; D008222:Lymphokines / Q000096:biosynthesis; D008264:Macrophages / Q000276:immunology / Q000502:physiology*; D011677:Punctures; D013154:Spleen / Q000473:pathology / Q000503:physiopathology*
D016207:Cytokines; D000949:Histocompatibility Antigens Class II; D008222:Lymphokines; D007371:Interferon-gamma